LifeSemantics said Tuesday that it has received approval from the Ministry of Food and Drug Safety (MFDS) to conduct a confirmatory clinical trial of its cardiovascular risk (hypertension complications) assessment AI software.The clinical trial will be a retrospective analytical study utilizing bloo
Young physicians from overseas have voiced their support for the resignations and allied leave of absence by Korean trainee doctors and medical students protesting the medical school enrollment quota increase.They also called for the Korean government to stop administrative penalties for collective
GI Innovation is accelerating the development of a subcutaneous (SC) formulation of its immuno-oncology candidate GI-102.The company said Tuesday that it has applied for approval to change the IND (investigational new drug) application for the GI-102 phase 1/2a clinical trial to the Ministry of Food
Saruparib, a next-generation PARP inhibitor in development by AstraZeneca, has garnered attention from cancer experts worldwide after showing clinical benefit in patients with homologous recombination repair-deficient (HRD) breast cancer.However, it is questionable whether Korean patients who face s
Curocell, a local chimeric antigen receptor-T (CAR-T) developer, said it will start developing a next-generation Anti-CD19 CAR-T therapy for treatment-resistant systemic lupus erythematosus (SLE) as part of the2024 Multi-Ministerial Regenerative Medicine Technology Development Program.This initiativ
Hugel, a total medical aesthetics company, said Tuesday that its polydioxanone (PDO) suture brand Licellvi (domestic product name: Blue Rose Forte) has received a product license from the Brazilian National Agency for Food and Drug Surveillance (ANVISA).Licellvi is a PDO suture brand of JWorld, a su
An increasing number of health supplements are differentiating themselves from traditional forms, such as capsules and pills, to various formulations, attempting to attract consumers with formulations that focus on portability and convenience of consumption.CJ ENM's digital marketing affiliate, Mezz
Menopausal women who experienced an early onset of vasomotor symptoms (VMSs), commonly known as hot flashes and night sweats, are at a higher risk of developing depressive symptoms, according to a study by Korean researchers.Professors Ryu Seung-ho, Chang Yoo-soo, and Dr. Choi Hye-rin at the Center
Daewoong Pharmaceutical said that it applied for product approval for Envlo, the first homegrown sodium-glucose cotransporter 2 (SGLT2) diabetes drug in Korea and the nation's 36th newly developed drug, to Mexico's Comisión Federal para la Protección contra Riesgos Sanitarios (COFEPRIS).COFEPRIS is
ViGenCell said Monday that it had initiated the Cohort 3 study, the final step of the phase 1 clinical trial of VT-Tri(1)-A for treating acute myeloid leukemia (AML).VT-Tri(1)-A is ViGenCell's first-in-class treatment for AML. It targets multiple common antigens. Last September, it began enrolling p
The Korea Exchange (KRX) has suspended stock trading of EONE-Diagnomics Genome Center (EDGC), a Kosdaq-listed genomic analysis company, due to unverified rumors that the company received a disclaimer of opinion during its audit process.The suspension took effect when the market opened Monday, with K
Celltrion said it has completed a registration contract for its subcutaneous (SC) Remicade biosimilar, Zymfentra (infliximab), with one of the top three pharmaceutical benefit managers (PBMs) in the United States."We are pleased to announce through our website that we have successfully closed a deal
The government said Monday that it would conduct an internal review of the Korean Medical Association (KMA)'s emergency committee's proposal to re-discuss increasing the number of medical students after a one-year moratorium.The government also said that although the enrollment quota has been alloca
Seegene, a Korean in vitro diagnostics company, recently hosted Jenny Harries, Chief Executive of the UK Health Security Agency (UKHSA), at its headquarters in Songpa-gu, Seoul.The visit, which took place on March 27, served as a platform for both parties to discuss innovative strategies to create a
Lunit said it published a study showing that using Lunit Insight MMG, its AI image analysis solution for mammography, can increase the likelihood of early breast cancer diagnosis and significantly reduce the workload of physicians.The study, conducted in collaboration with researchers from various u
Pinotbio is increasing its competitiveness on the global stage by emphasizing effectiveness and safety by combining the “PBX-7 Series” and “sequential cleavage linker.”Pinotbio, an ADC platform company, said Monday that it unveiled preclinical results of its ADC platform at the American Association
As the government and the medical community debate the increase in medical school enrollment quota, it has been suggested that Korea should learn from Japan, which increased medical school students and operates a regional quota system to solve the problem of regional medical disparities ahead of Kor
As the healthcare void continues due to a standoff between the government and the medical community over the increasing number of medical students, a patient group said it would ask the World Health Organization (WHO) to intervene in the ongoing medical crisis in Korea.The Korea Severe Disease Assoc
Amid a growing consensus that domestic and international medical practitioners should collaborate to find solutions to the growing risk of pancreatic and biliary tract diseases, some experts stressed the need for active state support for research investment to develop treatments and diagnostics.The
EuBiologics, a Korean vaccine maker targeting the global public health market, said it opened a new office at the Cambridge Innovation Center (CIC) in Boston, one of the largest biotech clusters in the world.EuBiologics' new office opening comes after their selection by KHIDI (Korea Health Industry